UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Position in IONS — Ionis Pharmaceuticals Inc
CIK 861177
NEW YORK, NY
Position in IONS
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$115,340,938
+$4,535,737 QoQ
Shares Held
1,454,672
-1.4% QoQ
Ownership
0.875%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#25
of 510 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 54%
Shared 0%
None 46%
Common Shares in IONS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $4,385,897,555 across 206 Biotechnology names. IONS ranks #7 (2.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,086,683 | $1,533,248,041 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
716,560 | $446,803,817 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
727,848 | $219,104,078 | |
| 4 | INCY |
Incyte Corp
|
1,508,720 | $171,028,494 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
912,335 | $170,862,094 | |
| 6 | INSM |
INSMED Inc
|
1,335,071 | $142,345,265 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
This page
|
1,454,672 | $115,340,938 | |
| 8 | MRNA |
Moderna, Inc.
|
1,521,849 | $106,575,080 |
All Filings in IONS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $115,340,938 | 1,454,672 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $110,805,201 | 1,475,632 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $109,849,531 | 1,388,567 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $75,505,534 | 1,154,166 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $31,255,248 | 791,072 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $19,895,149 | 659,435 | Shares | Defined | 2025-05-19 | |
| 2024-12-31 | $21,662,645 | 619,641 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $11,445,018 | 285,697 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $15,265,017 | 320,290 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $8,077,272 | 186,327 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $9,426,280 | 186,327 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $8,033,887 | 177,114 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $7,251,351 | 176,733 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $6,316,435 | 176,733 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $6,639,811 | 175,796 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $12,367,765 | 279,624 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $7,618,306 | 205,789 | Shares | Other | 2022-08-12 | |
| 2022-03-31 | $7,663,795 | 206,906 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $5,591,570 | 183,752 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $6,059,501 | 180,665 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $7,034,239 | 176,341 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $18,187,393 | 404,524 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $23,153,746 | 409,511 | Shares | Defined | 2021-03-01 | |
| 2020-09-30 | $16,555,253 | 348,899 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $19,966,211 | 338,640 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $17,055,405 | 360,732 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||